CryoLife, Inc. (CRY)’s Stock Is Buy After Forming Wedge Up

September 16, 2018 - By Catherine Diaz

CryoLife, Inc. (NYSE:CRY) Logo

Investors sentiment increased to 1.67 in Q2 2018. Its up 0.82, from 0.85 in 2018Q1. It improved, as 6 investors sold CryoLife, Inc. shares while 30 reduced holdings. 15 funds opened positions while 45 raised stakes. 24.77 million shares or 2.42% more from 24.19 million shares in 2018Q1 were reported.
Eam Investors Ltd Limited Liability Company reported 0.18% in CryoLife, Inc. (NYSE:CRY). Price T Rowe Assoc Incorporated Md invested in 16,761 shares or 0% of the stock. Legal General Group Public Limited Liability reported 66,700 shares stake. 12,179 are held by Ubs Asset Mgmt Americas. Blackrock holds 5.10 million shares. Connors Investor stated it has 91,805 shares. Capital Rech Glob holds 0.02% or 3.06M shares in its portfolio. Thrivent For Lutherans accumulated 23,119 shares. Jpmorgan Chase Company holds 0% or 51,011 shares in its portfolio. Nbw Limited Liability accumulated 59,875 shares. Teachers Retirement System Of The State Of Kentucky holds 0% or 6,073 shares in its portfolio. 58,500 are owned by Swiss Bancorporation. Northern Tru, a Illinois-based fund reported 1.21 million shares. California Employees Retirement Systems invested 0% of its portfolio in CryoLife, Inc. (NYSE:CRY). 614,939 are owned by Arrowmark Colorado Llc.

Since April 17, 2018, it had 0 buys, and 25 selling transactions for $9.83 million activity. 2,256 shares valued at $63,168 were sold by Horton Amy on Friday, June 1. Davis John E sold $80,016 worth of CryoLife, Inc. (NYSE:CRY) on Thursday, May 3. McCall Ronald D also sold $108,276 worth of CryoLife, Inc. (NYSE:CRY) on Wednesday, May 9. On Thursday, August 30 the insider Capps Scott B sold $215,921. The insider LEE DAVID ASHLEY sold 10,247 shares worth $337,924. Another trade for 42,675 shares valued at $1.42M was sold by Mackin James P.

The stock of CryoLife, Inc. (CRY) formed an up wedge with $37.24 target or 7.00 % above today’s $34.80 share price. The 5 months wedge indicates low risk for the $1.28 billion company. If the $37.24 price target is reached, the company will be worth $89.60 million more.
Rising wedges, especially for downward breakouts are tricky moments to trade. Investors must be aware that the break even failure rate for up or down breakouts is: 8% and 24%. The average rise is 28% and the decline is 14%. Wedges has high throwback and pullback rate: 73%, 63% and the percent of wedges meeting target is not more than 50%.

The stock increased 1.31% or $0.45 during the last trading session, reaching $34.8. About 107,697 shares traded. CryoLife, Inc. (NYSE:CRY) has risen 50.44% since September 16, 2017 and is uptrending. It has outperformed by 34.82% the S&P500.

Analysts await CryoLife, Inc. (NYSE:CRY) to report earnings on October, 29. They expect $0.06 earnings per share, down 25.00 % or $0.02 from last year’s $0.08 per share. CRY’s profit will be $2.21 million for 145.00 P/E if the $0.06 EPS becomes a reality. After $0.10 actual earnings per share reported by CryoLife, Inc. for the previous quarter, Wall Street now forecasts -40.00 % negative EPS growth.

CryoLife, Inc., together with its subsidiaries, makes and distributes medical devices worldwide. The company has market cap of $1.28 billion. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. It currently has negative earnings. The firm operates in two divisions, Medical Devices and Preservation Services.

CryoLife, Inc. (NYSE:CRY) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.